Sign Up | Log In | What is SocialPicks?

Par Pharmaceutical Companies Inc (PRX) Trade Now » Rate PRX - Discuss PRX - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Rate PRX:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

PRX Analysis & Videos »

... View All >

PRX: Bull or Bear?

Par Pharma and BioAlliance: Pipeline Analysis PRX

73%

+106.61%
in 216 days

MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, and Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX), announced the submission on April 7, 2009 of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the orally dissolving film strip (ODFS) formulation of ondansetron.

<> <> The NDA is supported by positive data from completed pivotal studies in which ondansetron ODFS demonstrated bioequivalence against G...

Continue reading »

By Mike Havrilla (+1.04% risk: conservative) 04/19/09

Comment

Updated FDA, Clinical Trial Calendars: CRME, MRK, LLY, PRX PRX

73%

-0.53%
in 9 days
(closed on 04/19/09)

Below is a summary of updates to the BioMedReports.com database of 242 entries included in the FDA and Clinical Trial Calendars .

http://biomedreports.com/fda-calendar.html

<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 115 entries through 4/9/09. The FDA Calendar includes the following information: company name, ticker, decision ...

Continue reading »

By Mike Havrilla (+1.04% risk: conservative) 04/10/09

Comment

Bullish on PRX ... PRX

62%

+142.25%
in 263 days

Par Pharmaceutical Companies, Inc., through its subsidiary, Par Pharmaceutical, Inc. develops, manufactures, and distributes generic and branded pharmaceuticals drugs in the United States. The company offers generic prescription drugs consisting of approximately 180 products representing various dosage strengths for approximately 80 separate drugs. Its generic products include metoprolol, fluticasone, propranolol ER, cabergoline, amoxicillin, ibuprofen Rx, tramadol HCl and acetaminophen tablets, megestrol oral suspension, fluoxetine, and methimazole. The company offers its drugs in the soli...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 03/03/09

Comment

... View All >

People Bullish on PRX

jonock

Analyst

N/A

about 1 mo ago

Mike Havrilla

Principal

73%

7 mos ago

Marian Filo

Principal

62%

8 mos ago

Statistician

Analyst

N/A

11 mos ago

Art

Analyst

N/A

11 mos ago

People Bearish on PRX

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	377
2	Gerald Greene	18.14	+70.10%	208
3	stockmarketfunding.com	17.66	+25.70%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.30%	38

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
DELL	Dell Inc
BA	The Boeing Company
PFE	Pfizer Inc
YHOO	Yahoo! Inc
GOOG	Google Inc
AAPL	Apple Computer Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

DNDN		BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen by Mike Havrilla
ONCY		Oncolytics Biotech Inc. down to 2,00 $ by Yannis Maarten
JNJ		Epinex Diagnostics: A New Paradigm for Diabetic Testing by Mike Havrilla
CERS		BioMed News Bytes: GeoVax, Cerus, Discovery Labs by Mike Havrilla
CVI		Short CVR Energy Inc (CVI) by stockexpert

... more »

StreetInsider.com on PRX

Par Pharmaceutical to Host Analyst Day on December 3rd

Par Pharma (PRX) Receives Final U.S. FDA Approval for Tramadol ER Doses

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER

Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Curren

Form 10-Q PAR PHARMACEUTICAL COMPA For: Oct 03

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Par Pharmaceutical Companies Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.